Catalog Number 326631 |
Device Problem
Material Separation (1562)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 07/27/2023 |
Event Type
malfunction
|
Manufacturer Narrative
|
H.3.A device evaluation is anticipated but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.
|
|
Event Description
|
It was reported that the hub separated from the bd ultra-fine¿ insulin syringe when the cap was removed.The following information was provided by the initial reporter, translated from japanese: "this report is about hub separation.When the cap was removed, the needle hub was taken off.".
|
|
Event Description
|
It was reported that the hub separated from the bd ultra-fine¿ insulin syringe when the cap was removed.The following information was provided by the initial reporter, translated from japanese: "this report is about hub separation.When the cap was removed, the needle hub was taken off.".
|
|
Manufacturer Narrative
|
H6: investigation summary customer returned a total of (19) 0.3ml 29ga 12.7mm syringes from the lot# 2234021, 14 in a sealed polybag, 5 in an open polybag.This report is about hub separation.When the cap was removed, the needle hub was taken off.The returned samples were visually examined and observed no issues, no issues were observed with needle hub separates.No issues of any kind was observed on the returned samples.A review of the device history record was completed for batch# 2234021.All inspections and challenges were performed per the applicable operations qc specifications except as noted below.There were zero (0) notifications noted that pertained to the complaint.Embecta was not able to confirm the customer indicated issue.Root cause cannot be determined as the issue is unconfirmed.
|
|
Search Alerts/Recalls
|